DNA protein targeted in ovarian cancer chemo test

University of Newcastle researcher Dr Nikola Bowden is investigating a DNA repair protein that is implicated in ovarian cancer tumours becoming resistant to chemotherapy, with hopes of eventually developing a prognostic test and more tailored treatments.

Indigenous health gap is closing too slowly

Close the Gap Day 2014 is a time to reflect on the progress we have made towards Aboriginal and Torres Strait Islander health equality. The Prime Minister’s Close the Gap Report 2014 highlighted that for Indigenous life expectancy, the pace of change is far too slow to close the gap by 2031.

Study of ‘minor strokes’ to prevent major impact

A community-based clinical trial that monitors people who have experienced a transient ischaemic attack (TIA) – colloquially known as a ‘minor stroke’ or ‘funny turn’ – is being expanded by researchers from the HMRI Stroke Group.

Cancer risk diagnosis ‘turbo-charged’ by new sequencer

An HMRI genetics laboratory at Newcastle’s John Hunter Hospital has become the first in Australia, and one of the few in the world, to receive accreditation for a new diagnostic system that revolutionises ‘NextGen’ DNA sequencing for breast and ovarian cancer.

‘Next’ big thing in DNA sequencing

To make a quantum leap in medical research you generally need the so-called ‘ducks’ to align – unmet patient needs, new technology, expertise and funding, mixed with serendipitous timing.